Really enjoyed this new podcast episode with @quailty.
Three great segments. About his book about a country of all blind people. The history of braille. And living with low vision.
https://t.co/JtgPU0e9tk
We are thrilled to announce the FDA has approved the first-ever therapy for people living with #GeographicAtrophy (GA).
GA is an irreversible and progressive retinal disease that impacts over a million people in the U.S.
5 years ago, I started tweeting additionally as @stargardtp focused on stargardtians and research advances for therapies and cures. Still much work to do! #abca4#stargardt
Ascidian’s lead program addresses mutations of the #ABCA4 gene that lead to inherited eye disorders such as #Stargardtdisease, a genetically driven form of vision loss with no FDA-approved therapies.
Stargardt disease causes increasing loss of central and night vision. Researchers from our intramural program developed a model to better understand Stargardt and to develop treatments for it. Read more: https://t.co/e0CJQlvAwn
#NEIResearchNews
In this week's #EyeOnTheCurePodcast episode, host Ben chats with Rando Allikmets, PhD, from @Columbia, about his remarkable and serendipitous discovery more than two decades ago of #ABCA4, the gene associated with #Stargardt disease. https://t.co/JtOlHLgZbB
Not sure why this wasn’t tweeted by @NatEyeInstitute yet… I got the link via an email newsletter from NEI that you can subscribe to via:
https://t.co/5UD5iUQL5s
3/
"1st report where loss of ABCA4 function in human RPE has been associated with intracellular lipid deposits in those cells, w/o exposure to ABCA4 mutant photoreceptor outer segments. Over time, these lipid deposits may contribute to RPE atrophy => photoreceptor degeneration."
2/
@belite_bio submits an IND application to the FDA to support Phase 3 development of LBS-008, the Company’s orally administered treatment for #Stargardt Disease (STGD1).
Article: https://t.co/jdhXvCCxlg
#ClinicalTrials#Ophthalmology
@Nanoscope's MCO-010 clinical trial offers hope for patients with #Stargardt macular degeneration. Patients with severe #visionloss typically lack sufficient light-sensing photoreceptor neurons needed to qualify for experimental ABCA4 #therapies.
Story: https://t.co/BgAy6VOyko
Testing for #COVID19 can be challenging for those that are visually impaired. The Administration launched a new initiative to distribute free, accessible home tests to those who are blind or have low vision. The tests use an app to provide audible results
https://t.co/WaTbHal7BR
I'm building a clinical trial viewer/search tool for a variety of uses. If this is interesting to you, follow my other account: @rrelyea ...and get in touch.
Link to an example with a prebuilt list of retinal conditional search terms: https://t.co/YkglSupPWG
Picture: